Industry NewsCOVID-19 therapeutic treatment is world's first synthetic biological drug to receive FDA approval for phase III trials
Expert InsightsExpand your laboratory capabilities with the Agilent StreamSelect LC/MS system: Your questions answered
Industry NewsAbivax’s COVID-19 phase 2b/3 trial with ABX464 declared research national priority by the French government’s clinical trial council